« Back
Home /
Polyclonal Antibody to Mitogen Activated Protein Kinase 14 (MAPK14)

Polyclonal Antibody to Mitogen Activated Protein Kinase 14 (MAPK14)

Item no.	PAB206Hu01-10ug
Manufacturer	Cloud-Clone
Amount	10 ug
Quantity options	100 ul 10 ug 1 ml 200 ul 20 ul 500 ul 50 ug
Category	Oncology Neuroscience Neural Lineage Markers Neural Signaling Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Myeloma Melanoma Sarcoma Immunohistochemistry Western Blot ELISA Immunocytochemistry Primary Antibodies Glial Cell Markers
Type	Antibody Polyclonal
Format	Liquid
Applications	WB, IP, IHC, ICC
Specific against	Human (Homo sapiens)
Host	Rabbit
Citations	Isolation and characterization of anti-inflammatory and anti-proliferative compound, for B-cell Non-Hodgkin lymphoma, from Nyctanthes arbor-tristis Linn.
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	CSBP1,CSBP2,CSPB1,EXIP,Mxi2,PRKM14,PRKM15,RK,SAPK2A,P38,Mitogen-activated protein kinase p38 alpha,Cytokine suppressive anti-inflammatory drug-binding protein
Available
Manufacturer - Category	Primary Ab
Manufacturer - Research Area	Signal transduction, Enzyme & Kinase, Tumor immunity, Infection immunity,
Buffer Formulation	0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen	RPB206Hu01-Recombinant Mitogen Activated Protein Kinase 14 (MAPK14)
Usage	Western blotting: 0.5-2µg/mL; < br/> Immunohistochemistry: 5-20µg/mL; < br/> Immunocytochemistry: 5-20µg/mL; < br/> Optimal working dilutions must be determined by end user.
Purification	Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.